Compare FGBIP & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FGBIP | MDAIW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 339 | 78 |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | FGBIP | MDAIW |
|---|---|---|
| Price | $17.88 | $0.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.5K | ★ 9.7K |
| Earning Date | N/A | 02-27-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,264,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 44.52 |
| 52 Week Low | $14.42 | $0.26 |
| 52 Week High | $20.44 | $1.01 |
| Indicator | FGBIP | MDAIW |
|---|---|---|
| Relative Strength Index (RSI) | 49.84 | 47.12 |
| Support Level | $17.61 | $0.37 |
| Resistance Level | $18.07 | $0.61 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 0.00 | 43.55 |
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.